Stock listing

Axogen, Inc.

Selected listing: LT3 · SWB · EUR · DE

Axogen, Inc. (Stuttgart:LT3), Health Technology. Latest release Oct 1, 2026: Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™…

LT3:SWBEURDEUpdated October 2, 2026

Ticker: Stuttgart:LT3
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Stuttgart
Currency: EUR

Latest news from Axogen, Inc.

Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair

October 1, 2026

Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock

September 10, 2026

Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies

September 10, 2026

Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference

September 1, 2026

Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology

July 29, 2026

All Axogen, Inc. news →

Events

Replays

Axogen, Inc. (AXGN) Q2 2026 Earnings Call
Wed, Jul 29, 2026 · 08:00 AM ET
Watch
Axogen, Inc. (AXGN) Q1 2026 Earnings Call
Tue, Apr 28, 2026 · 08:00 AM ET
Watch
Axogen, Inc. (AXGN) Q4 2025 Earnings Call
Tue, Feb 24, 2026 · 08:00 AM ET
Watch

Research Axogen, Inc.

Axogen, Inc. company profile

View the public company page for Axogen, Inc. on 6ix.

Axogen, Inc. news

Read company news and market updates connected to Axogen, Inc..

Axogen, Inc. investor events

Find investor webinars, events, and replay context for Axogen, Inc..